Spinal Cord Injury and Bowel Dysfunction
Download
Report
Transcript Spinal Cord Injury and Bowel Dysfunction
Spinal Cord Injury and Bowel
Dysfunction
Presented by Angela Stancil
January 10 , 2014
Epidemiology of SCI
200,000 - 273,000 people in U.S. have SCI
Estimated 12,000 – 20,000 new cases in U.S. annually
Average age at time of injury 42.6 y/o
80.7% males
76.8% Caucasian
Alcohol implicated in 25% of cases
A&P of the Spinal Column
SCI Classifications
Complete or
Incomplete
Quadraplegia
Tetraplegia
Paraplegia
Monoplegia
Complications of SCI
Lack of bladder control
Bowel Dysfunction
Spacisity
Altered or missing skin
sensation
Flaccidity
Problems with circulatory
control
Orthostatic hypotension
Autonomic Hyperreflexia
Edema
Respiratory problems
Altered muscle tone
Muscle atrophy
Weight loss (new injury)
Loss of Mobility
Sexual Dysfunction
Depression
Pain
Autonomic Hyperreflexia
Neurogenic Bowel
Problems with storing, removing, or moving stool from the
intestines resulting from nerve damage
Classifications
–
Reflexic Bowel
–
Areflexic Bowel
Symptoms of Neurogenic Bowel
Trouble having a bowel movement
Repeated bowel accidents
Swollen abdomen
Feeling full (not hungry) quickly
Loose stools or very hard stools
Bleeding from the rectum
Abdominal pain
Treatment/Bowel Training
Dietary changes
Exercise/PA program
Specific times, assistance, and positions for BMs
Medications (stool softeners, laxatives, colonic
stimulants, bulking agents)
Digital Stimulation (mechanical, enemas, suppositories)
Surgery (Colostomy or Ileostomy)
Rationale and Study Objectives
Moisture content of stool remains 70-75%
Low fiber intake does not = constipation
Symptoms may increase with increased fiber intake
Other treatments (i.e. lactulose) may be more beneficial
than fiber
Patients with constipation already have high fiber intake
Objective: to study the effect of decreasing fiber in patients
with constipation
Hypothesis: Reducing dietary fiber reduces fecal bulk
making defecation easier
Study Design
Prospective longitudinal case study
Inclusion criteria:
Straining to expel bulky stools
Bowel frequency <1 per 3 days over 3 months
Exclusion criteria:
Colorectal cancer, previous colonic surgery,
melanosis coli, thyroid disorders, anal problems
63 subjects enrolled in the study
Methods
Each patient acted as their own control
No dietary intake of fiber for 2 weeks
Normal CHOs and protein
No laxatives
Sieved juices and clear vegetables soups
Low fiber diet
F/U at 1 month and 6 months
Methods
Data Collection:
Age & sex
Fiber intake
Frequency of BMs
Straining difficulty
Evacuation difficulty
Abdominal pain and bloating
Anal Bleeding
Statistical analysis
Paired t tests using SPSS software
Results
16 males, 47 females
Median age 47 years
High fiber diet + fiber supplement
At 6 months:
41 no fiber, 16 reduced fiber, 6 high fiber
Results - Demographics
No significant difference in age or sex between groups
Results – BM Frequency
Group
Baseline
6 months
P value
1 motion/ 3.75 days
(+/- 1.59 days)
1 motion/ 1.0 days
(=/- 0.00 days)
P < 0.001
Reduced Fiber
(n = 16)
1 motion/ 4.19 days
(+/- 2.09 days)
1 motion / 1.9 days
(+/- 1.21 days)
P <0.001
High Fiber (n = 6)
1 motion/6.83 days
(+/- 1.03 days)
1 motion/6.83 days
(+/- 1.03 days)
P <1.00
No Fiber (n=41)
Net Effect: Increase in frequency in No Fiber and Low Fiber
groups, no change in High Fiber group
Results – Associated Symptoms
Net Effect: Reduction in associated symptoms in Reduced
and No Fiber groups
Conclusions
Authors' Conclusions:
Removing dietary fiber improves constipation and
associated symptoms
Study Limitations
Small sample size
No baseline symptoms by group
P values
Results not generalizable
Rationale
IBS is a functional bowel disorder characterized by abdominal
pain and discomfort related to bowel disturbances
Probiotics are a safe candidate for controlling IBS symptoms
Dietary fiber is commonly used in the treatment of IBS
Objective: Evaluate the effect of probiotics on patients with IBS
and determine if dietary fiber has an additive effect
Study Design
Single center, randomized, control trial
Recruited volunteers ages 18 – 70 y/o
Exclusion criteria:
Severe liver, lung, renal, hematological, or major psychiatric
disorder
Adults > 50 y/o who had not had colonoscopy or
sigmoidoscopy in past 5 years
Abnormal thyroid function, blood counts, serum chemistry
Antipsychotics or anticholergenics in past month
Pregnant or lactating
Receiving medications for IBS
Methods
142 participants
Each participant received a
fermented milk product taken
2x/day for 4 weeks
Control group: 150 ml milk +
Probiotics
Test group: same + 3.15 g
dietary fiber
Questionnaire
Primary endpoint: difference in
defecation frequency, duration,
and VAS score
Statistical Analysis
Shapiro-Wilk test
Student t tests
Paired t tests
P < 0.05
Results
Results
Results
Results
Authors' Conclusions:
Plain probiotic milk and probiotic milk containing fiber are
safe and effective. Probiotic milk containing fiber was more
effective for the constipation dominant subtype of IBS
Study Limitations:
No placebo group
Mr. W
57 y/o AAM w/ C4 quadreplegia
PMH: neurogenic bowel and bladder w/ chronic indwelling catheter,
ventilator dependent respiratory failure s/p trach (capped),
osteomyelitis, migraines, anemia, keratoderma, and VRE
BT: Digital Stimulation, Mini enema
Skin: Braden 10, Severe risk of HAPU
Stage 4 PU to clavicle and R. ischeal
Stage 3 PU to Sacrum
Unstageable PU to R. heel
Mr. W
Laboratory Data: No new lab data
Previously, low pre – albumin (17.39)
Anthropometrics
HT: 74 in.
WT: 130.1 lbs (12/8/13)
130.2 lbs (11/21/13)
126 lbs. (11/15/13)
DBW: 162 – 171 lbs. (adjusted 5-10% for tetraplegia)
%DBW: 80%
Pertinent Medications:
Omeprazole, Acidophilus, Docusate, Tizanidine, Baclofen
Nutrition Assessment
Estimated Nutrition Needs
Calories: 1776 – 2072 kcals/day (30-35 kcals/kg)
Protein: 74 – 89 g (1.25 – 1.5 g/kg)
Fluid: 1 ml/kcal + 500 ml or per PCP
Diet Hx:
PO: Liberal diet
EN: TwoCal @ 60 ml/hr x 12 hrs
Free water @ 250 ml/hr q4h
Prostat supplement
10 am: orange/mango applesauce (meds only)
8pm snack: PB &J, 1 choc milk, 1 cookie
Nutrition Assessment
Nutrition Assessment
Appetite: “so so”
No V/C/D
Tolerating TF w/o problems
Physical Assessment
Moderate deficits in temples and OFP
24 hour calorie count: 381 kcals, 16.1 g protein
Nitrogen Balance: + 2.57 (PO + EN+ Prostat)
Mr. W
Nutrition Dx:
Increased protein/energy needs related to malnutrition and
wound healing as evidenced by presence of multiple PUs
and Braden of 9.
Inadequate oral intake related to poor appetite as evidenced
by ongoing need for nutrition support and results of 24 hour
calorie count.
Nutrition Prescription:
Increase intake by 10% by next visit utilizing supplements,
snacks, and select menus thereby decreasing dependence on
EN
Mr. W
Nutrition Interventions
Continue Liberal diet
Continue Prostat and evening snack
Continue EN : TwoCal @ 60 ml/hr from 7p - 7a
Nutrition Monitors
Wound healing
Tolerating TF
Prevent Unintentional Weight loss
Lab values WNL
Consume >80% nutrition needs
Mr. W
Nutrition Evaluation
Patient's PO intake remains suboptimal. With EN,
patient's nitrogen balance is positive. Recommend
continuing Liberal diet and EN. Encourage PO
intake to decrease dependence on nutrition
support. Will continue to follow while admitted.
Prognosis: ??
References
The University of Alabama at Birmingham NSCISC National Spinal Cord Injury Statistical Center. Spinal Cord
Injuries Facts and Figures at a Glance. Updated February 2013.Accessed January 5, 2014. Available at
https://www.nscisc.uab.edu/.
The Centers for Disease Control and Prevention. Spinal Cord Injury (SCI): Fact Sheet. CDC's Injury Center
webpage. Updated November 4, 2010. Accessed January 5, 2014. Available at
http://www.cdc.gov/traumaticbraininjury/scifacts.html.
The Mayo Clinic. Spinal Cord Injury. Diseases and conditions webpage. Updated Oct. 22, 2011 . Accessed
January 5,2014. Available athttp://www.mayoclinic.org/diseases-conditions/spinal-cordinjury/basics/definition/con-20023837.
National Institutes of Health Clinical Center. Managing Bowel Dysfunction patient education handout.
Accessed January 5, 2014. Available at http://www.cc.nih.gov/ccc/patient_education/pepubs/bowel.pdf.
NYU Langone Medical Center. Neurogenic Bowel. Diseases and conditions webpage. Updated March 2013.
Accessed January 5, 2014. Available at http://medicine.med.nyu.edu/conditions-wetreat/conditions/neurogenic-bowel. http://medicine.med.nyu.edu/conditions-we-treat/conditions/neurogenicbowel.
Ho, K, Tan, CY, Daud MA, Seow-Choen, F. Stopping or reducing dietary fiber intake reduces constipation and
its associated symptoms. World J Gastroenterology. 2012;18(33):4593-4596.
Choi,SC, Kim BJ,Rhee P, et al. Probiotic fermented milk containing dietary fiber has additive effects in IBS
with constipation compared to plain probiotic fermented milk. Gut and Liver; 2011.(5):22 – 28.